The Notch pathway differs from Wnt, Hedgehog, and BMP signaling in a fundamental way. What is this difference?
ANotch signaling requires direct physical contact between the signal-sending and signal-receiving cells, because the ligand (Delta/Jagged) and receptor (Notch) are both transmembrane proteins — no diffusible morphogen is involved
BNotch is the only pathway that uses transcription factors
CNotch signaling is unique to vertebrates; the other pathways exist in all animals
DNotch does not involve gene expression changes
Wnt, Hedgehog, and BMP all use secreted, diffusible ligands that can act over distances (morphogen gradients). Notch requires juxtacrine signaling — the Delta/Jagged ligand on one cell's surface directly engages the Notch receptor on the adjacent cell's surface. This mechanical interaction triggers proteolytic cleavage of Notch, releasing its intracellular domain (NICD), which translocates to the nucleus and activates transcription. This contact-dependent mechanism makes Notch uniquely suited for local cell-fate decisions between immediate neighbors (like lateral inhibition), while the other pathways can pattern tissues over longer ranges.
Question 2 True / False
When Wnt ligand binds its receptor Frizzled and co-receptor LRP5/6, it prevents the destruction complex from degrading beta-catenin. Without Wnt, beta-catenin is constitutively destroyed.
TTrue
FFalse
Answer: True
The Wnt pathway is unusual in that the 'default' state (no signal) involves active destruction of the key effector. The destruction complex (APC, Axin, GSK3-beta, CK1) phosphorylates beta-catenin, marking it for ubiquitination and proteasomal degradation. When Wnt ligand engages Frizzled and LRP5/6, Axin is recruited to the membrane, disrupting the destruction complex. Unphosphorylated beta-catenin accumulates, enters the nucleus, binds TCF/LEF transcription factors, and activates target genes. This 'double-negative' logic (signal inhibits an inhibitor) means that mutations inactivating APC (a component of the destruction complex) constitutively activate Wnt signaling — this is the initiating event in most colorectal cancers.
Question 3 Short Answer
Why are the same four signaling pathways reused throughout development rather than the organism evolving specialized pathways for each organ?
Think about your answer, then reveal below.
Model answer: Reusing a small toolkit of well-characterized pathways is more evolvable than inventing new pathways for each context. The pathways themselves provide the signaling logic (activate/repress target genes), while specificity comes from the cellular context — which transcription factors are already present, which chromatin regions are accessible, and which pathway components are expressed. A cell in the neural tube and a cell in the limb bud can both receive Shh signaling but interpret it differently because they express different transcription factors. This context-dependent interpretation means evolutionary innovation can occur by changing when and where a pathway is active (regulatory mutations) without redesigning the signal transduction machinery. This is far more mutationally accessible than evolving new receptor-ligand pairs.
This principle — versatile reuse of a limited toolkit — is one of the core insights of evo-devo. It explains why loss-of-function mutations in developmental signaling pathways tend to have pleiotropic effects (disrupting multiple organs that use the same pathway) and why gain-of-function mutations in these pathways are common drivers of cancer.